Cargando…
Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
Introduction Rheumatoid arthritis is a chronic, inflammatory, and multisystem disease, which, along with the joints, can involve the cardiovascular system. The treatment of rheumatoid arthritis or rheumatoid arthritis itself can lead to atherosclerosis, which is considered one of the major causes by...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823064/ https://www.ncbi.nlm.nih.gov/pubmed/33505813 http://dx.doi.org/10.7759/cureus.12246 |
_version_ | 1783639756188418048 |
---|---|
author | Mal, Kheraj Kumar, Ratan Mansoor, Farah Kaur, Navneet Kumar, Anil Memon, Sidra Rizwan, Amber |
author_facet | Mal, Kheraj Kumar, Ratan Mansoor, Farah Kaur, Navneet Kumar, Anil Memon, Sidra Rizwan, Amber |
author_sort | Mal, Kheraj |
collection | PubMed |
description | Introduction Rheumatoid arthritis is a chronic, inflammatory, and multisystem disease, which, along with the joints, can involve the cardiovascular system. The treatment of rheumatoid arthritis or rheumatoid arthritis itself can lead to atherosclerosis, which is considered one of the major causes by which it can affect the cardiovascular system. In this study, we will assess the risk of cardiovascular events in patients with rheumatoid arthritis as compared to the general population. Method This case-control study was conducted from January 2018 to November 2018. Two-hundred twenty-two (222) patients with diagnosed rheumatoid arthritis were included as cases in the study. Two-hundred eleven (211) patients were included in the study as the control group (patients without rheumatoid arthritis). All the data were recorded in a self-structured questionnaire. Result Participants with rheumatoid arthritis also showed an increased risk of myocardial infarction (MI) by an odds ratio of 2.50 (95% CI; 0.77-8.14). There was also an increased risk of cardiovascular death in participants with rheumatoid arthritis by an odds ratio of 1.99 (0.58-6.71). Conclusion The study suggests that rheumatoid arthritis along with joint inflammation can also affect the cardiovascular system. Hence, a multidisciplinary team of rheumatologists and cardiologists should manage patients suffering from rheumatoid arthritis, which will improve morbidity and mortality in such patients. |
format | Online Article Text |
id | pubmed-7823064 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-78230642021-01-26 Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Mal, Kheraj Kumar, Ratan Mansoor, Farah Kaur, Navneet Kumar, Anil Memon, Sidra Rizwan, Amber Cureus Cardiology Introduction Rheumatoid arthritis is a chronic, inflammatory, and multisystem disease, which, along with the joints, can involve the cardiovascular system. The treatment of rheumatoid arthritis or rheumatoid arthritis itself can lead to atherosclerosis, which is considered one of the major causes by which it can affect the cardiovascular system. In this study, we will assess the risk of cardiovascular events in patients with rheumatoid arthritis as compared to the general population. Method This case-control study was conducted from January 2018 to November 2018. Two-hundred twenty-two (222) patients with diagnosed rheumatoid arthritis were included as cases in the study. Two-hundred eleven (211) patients were included in the study as the control group (patients without rheumatoid arthritis). All the data were recorded in a self-structured questionnaire. Result Participants with rheumatoid arthritis also showed an increased risk of myocardial infarction (MI) by an odds ratio of 2.50 (95% CI; 0.77-8.14). There was also an increased risk of cardiovascular death in participants with rheumatoid arthritis by an odds ratio of 1.99 (0.58-6.71). Conclusion The study suggests that rheumatoid arthritis along with joint inflammation can also affect the cardiovascular system. Hence, a multidisciplinary team of rheumatologists and cardiologists should manage patients suffering from rheumatoid arthritis, which will improve morbidity and mortality in such patients. Cureus 2020-12-23 /pmc/articles/PMC7823064/ /pubmed/33505813 http://dx.doi.org/10.7759/cureus.12246 Text en Copyright © 2020, Mal et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Cardiology Mal, Kheraj Kumar, Ratan Mansoor, Farah Kaur, Navneet Kumar, Anil Memon, Sidra Rizwan, Amber Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis |
title | Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis |
title_full | Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis |
title_fullStr | Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis |
title_full_unstemmed | Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis |
title_short | Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis |
title_sort | risk of major adverse cardiovascular events in patients with rheumatoid arthritis |
topic | Cardiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823064/ https://www.ncbi.nlm.nih.gov/pubmed/33505813 http://dx.doi.org/10.7759/cureus.12246 |
work_keys_str_mv | AT malkheraj riskofmajoradversecardiovasculareventsinpatientswithrheumatoidarthritis AT kumarratan riskofmajoradversecardiovasculareventsinpatientswithrheumatoidarthritis AT mansoorfarah riskofmajoradversecardiovasculareventsinpatientswithrheumatoidarthritis AT kaurnavneet riskofmajoradversecardiovasculareventsinpatientswithrheumatoidarthritis AT kumaranil riskofmajoradversecardiovasculareventsinpatientswithrheumatoidarthritis AT memonsidra riskofmajoradversecardiovasculareventsinpatientswithrheumatoidarthritis AT rizwanamber riskofmajoradversecardiovasculareventsinpatientswithrheumatoidarthritis |